146 related articles for article (PubMed ID: 32769866)
1. A systematic review and meta-analysis protocol of clinical characteristics and prognostic significance of mammalian target of rapamycin for gastric cancer patients.
Wang H; Li J
Medicine (Baltimore); 2020 Aug; 99(32):e21138. PubMed ID: 32769866
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylated Mammalian Target of Rapamycin p-mTOR Is a Favorable Prognostic Factor than mTOR in Gastric Cancer.
Cao GD; Xu XY; Zhang JW; Chen B; Xiong MM
PLoS One; 2016; 11(12):e0168085. PubMed ID: 28005970
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. STAT3-induced lncRNA HAGLROS overexpression contributes to the malignant progression of gastric cancer cells via mTOR signal-mediated inhibition of autophagy.
Chen JF; Wu P; Xia R; Yang J; Huo XY; Gu DY; Tang CJ; De W; Yang F
Mol Cancer; 2018 Jan; 17(1):6. PubMed ID: 29329543
[TBL] [Abstract][Full Text] [Related]
5.
Xiang L; Wang W; Zhou Z; Lv M; Tao L; Ni T; Deng J; Masatara S; Liu Y; Zhou Y
Biomark Med; 2020 Apr; 14(6):421-432. PubMed ID: 32175764
[No Abstract] [Full Text] [Related]
6. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA hsa_circ_0010882 promotes the progression of gastric cancer via regulation of the PI3K/Akt/mTOR signaling pathway.
Peng YK; Pu K; Su HX; Zhang J; Zheng Y; Ji R; Guo QH; Wang YP; Guan QL; Zhou YN
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1142-1151. PubMed ID: 32096170
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer: A protocol for systematic review and meta-analysis.
Zhang M; Huang W; Yuan D
Medicine (Baltimore); 2021 Apr; 100(17):e25747. PubMed ID: 33907170
[TBL] [Abstract][Full Text] [Related]
9. Significant association of DIRC1 overexpression with tumor progression and poor prognosis in gastric cancer.
Li Z; Yang AJ; Wei FM; Zhao XH; Shao ZY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8682-8689. PubMed ID: 30575946
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
11. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
12. P-mTOR Expression and Implication in Breast Carcinoma: A Systematic Review and Meta-Analysis.
Ding XF; Li LF; Zhou XL; Guo LN; Dou MM; Chi YY; Wu SX; Zhang YN; Shan ZZ; Zhang YJ; Wang F; Fan QX; Zhao J; Sun TW
PLoS One; 2017; 12(1):e0170302. PubMed ID: 28114374
[TBL] [Abstract][Full Text] [Related]
13. Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
Cao GD; Chen K; Chen B; Xiong MM
BMC Cancer; 2017 Dec; 17(1):841. PubMed ID: 29233126
[TBL] [Abstract][Full Text] [Related]
14. Huachansu Capsule inhibits the proliferation of human gastric cancer cells via Akt/mTOR pathway.
Ni T; Wang H; Li D; Tao L; Lv M; Jin F; Wang W; Feng J; Qian Y; Sunagawa M; Liu Y
Biomed Pharmacother; 2019 Oct; 118():109241. PubMed ID: 31351435
[TBL] [Abstract][Full Text] [Related]
15. Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: a meta-analysis.
Min L; Chen J; Yu M; Yang K; Liu D
Biomarkers; 2023 Dec; 28(5):427-436. PubMed ID: 37036017
[No Abstract] [Full Text] [Related]
16. CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.
Agah E; Saleh F; Sanjari Moghaddam H; Saghazadeh A; Tafakhori A; Rezaei N
Syst Rev; 2018 Dec; 7(1):237. PubMed ID: 30572951
[TBL] [Abstract][Full Text] [Related]
17. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR.
Yin C; Ke X; Zhang R; Hou J; Dong Z; Wang F; Zhang K; Zhong X; Yang L; Cui H
FASEB J; 2019 Dec; 33(12):14036-14050. PubMed ID: 31647887
[TBL] [Abstract][Full Text] [Related]
18. Correlation between tumor marker CA72-4 and prognosis of patients with gastric cancer: A protocol for systematic review and meta-analysis.
Li M; Xue F; Yang J; Pan X
Medicine (Baltimore); 2020 Dec; 99(52):e23723. PubMed ID: 33350753
[TBL] [Abstract][Full Text] [Related]
19. HER3, but Not HER4, Plays an Essential Role in the Clinicopathology and Prognosis of Gastric Cancer: A Meta-Analysis.
Cao GD; Chen K; Xiong MM; Chen B
PLoS One; 2016; 11(8):e0161219. PubMed ID: 27536774
[TBL] [Abstract][Full Text] [Related]
20. The GAS5/miR-222 Axis Regulates Proliferation of Gastric Cancer Cells Through the PTEN/Akt/mTOR Pathway.
Li Y; Gu J; Lu H
Dig Dis Sci; 2017 Dec; 62(12):3426-3437. PubMed ID: 29098549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]